In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 36 for your search:
Drug:  selumetinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: 09-20-HEP, NCT01029418

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ABC-04, 2010-018522-39, NCT01242605

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00012, NCT00372788

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00008, NCT00372944

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2009-00604, GOG-0239, CDR0000563965, U10CA027469, NCT00551070

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00251, OSU 07056, CDR0000573452, N01CM62208, N01CM62207, 07056, 7932, NCT00553332

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01056, CDR0000574262, LOI 7918, 7918, P30CA076292, N01CM62203, N01CM62201, N01CM62208, MCC-15305, MCC-LOI-7918, NCT00559949

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00250, 15455B, N01CM62209, N01CM62201, UCCRC-15455B, 7925, NCT00588809

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01164, MSKCC-09003, CDR0000637669, 09-003, 8252, N01CM62206, NCT00866177

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00576, CDR642346, 09-005, 8281, P30CA006516, U01CA062490, N01CM62206, NCT00888134

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00016, NCT00890825

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00006, NCT00936221

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01958, CDR0000651456, GOG-0229H, U10CA027469, NCT01011933

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02929, CDR669144, NCI-8631, 8631, P30CA076292, N01CM00100, N01CM00071, NCT01085214

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D9010C00009, AGICC 09CRC02, NCT01116271

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01411, CDR0000674866, 10-053, 8443, N01CM00071, N01CM00099, N01CM62206, N01CM00070, N01CM00100, P30CA008748, N01CM62208, U01CA132123, MSKCC-10053, NCT01143402

17.

Phase: Phase II
Type: Tissue collection/Repository, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: Other
Protocol IDs: SAKK 21/08, SWS-SAKK-21/08, EUDRACT-2010-019965-27, EU-21046, CDR0000680800, NCT01160718

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2011-02532, CDR0000685408, CHNMC-PHII-95, NCCN-T06, PHII-95, 8412, P30CA033572, N01CM00038, NCT01206140

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01266, CDR0000686634, UCSF-10454, 10454, 8598, N01CM00070, P30CA082103, R21CA149939, USCF-10454, NCT01222689

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 100218, 10-C-0218, NCT01229150

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: OCTO_015, NCT01256359

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110117, 11-C-0117, NCT01333475

23.

Phase: Phase II
Type: Tissue collection/Repository, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01993, CDR0000737878, SWOG-S1115, S1115, U10CA180888, U10CA032102, NCT01658943

24.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00005, NCT00463814

25.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00004, NCT00600496
1   
New Search